Lynch syndrome is an inherited disorder associated with many different cancers including ovarian, uterine, pancreatic and, most commonly, colorectal. It is estimated that about one in 279 people are Lynch syndrome carriers, or about 1 million people in the U.S. Dr. Jordan Karlitz, Senior Medical Director at GRAIL, and Robin Dubin, Executive Director and Co-founder of AliveandKick'n – a patient advocacy organization focused on Lynch syndrome – join The Cancer SIGNAL to discuss risks associated with hereditary cancer predispositions, the need for tailored screening programs and how multi-cancer early detection could be used to look for cancers associated with Lynch syndrome.  AliveandKick'n: https://www.aliveandkickn.org/  Sign up for GRAIL's monthly newsletter: http://bit.ly/3ZBt6IK

Ver todos los episodios